Skip to Content

Notice

Cardiovascular and Renal Drugs Advisory Committee; Cancellation

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 16506

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is canceling the meeting of the Cardiovascular and Renal Drugs Advisory Committee scheduled for April 5, 2005. This meeting was announced in the Federal Register of March 9, 2005 (70 FR 11678).

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Cathy A. Groupe, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, e-mail: Groupc@cder.fda.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area) code 3014512533.

Start Signature

Dated: March 24, 2005.

Sheila Dearybury Walcoff,

Associate Commissioner for External Relations.

End Signature End Further Info End Preamble

[FR Doc. 05-6331 Filed 3-25-05; 3:50 pm]

BILLING CODE 4160-01-S